L’EGA è un gruppo ombrello pan europeo che rappresenta gli interessi dei pazienti Gaucher e quelli dei gruppi di pazienti Gaucher non a scopo di lucro in tutta Europa e altrove nel mondo.
Italiano ▼ login ▼
COLLEGATI AD UNO DEI NOSTRI 41 PAESI MEMBRI PER SOSTEGNO, CONSIGLIO E NOTIZIE A LIVELLO LOCALE
Vedi mappa
chiudi- Finland
- Norway
- Sweden
- Estonia
- Russian Federation
- Latvia
- Denmark
- Lithuania
- United Kingdom
- Netherlands
- Ireland
- Poland
- Germany
- Belgium
- Czech Republic
- Ukraine
- Slovakia
- Luxembourg
- Moldova, Republic of
- Austria
- France
- Switzerland
- Romania
- Slovenia
- Croatia
- Serbia
- Bosnia & Herzegovina
- Bulgaria
- Italy
- Macedonia, the Former Yugoslav Republic of
- Spain
- Greece
- Israel
Notizie
Become an IGA Volunteer
17 marzo 2021
We need volunteers to join us and support us in successful achievement of our goals and 2021 work programme. We have several opportunities open at this moment so please take a look and let us know if you are available to volunteer for us.
…February 2021 newsletter
8 marzo 2021
Sharing our latest newsletter which includes details of our first webinar for 2021, a message of thanks from a young Jordanian patient and the publication of our latest GD booklet to mark Rare Disease Day 2021
You can read the newsletter in full …
Gaucher disease booklet
22 febbraio 2021
To mark Rare Disease Day 2021, we are pleased to publish our new information booklet on Gaucher disease Types 1, 2 and 3: DOWNLOAD THE BOOKLET HERE
We have developed this booklet as a source of information for patients and their carers and to …
PR001 in development by Prevail Therapeutics
4 febbraio 2021
PR001 in development by Prevail Therapeutics
Prevail Therapeutics, a wholly-owned subsidiary of Eli Lilly and Company, is developing an investigational gene therapy called PR001 that has the potential to slow or stop the underlying …
January 2021 newsletter
19 gennaio 2021
Our first newsletter of 2021 is now available to read, sharing with you the opportunity to get involved in our Gene Therapy focus group and a joint statement with the EWGGD on COVID-19 vaccinations for patients with Gaucher disease.
Gene Therapy Focus Group
14 gennaio 2021
The IGA is looking for Gaucher patients and parent/caregivers to join a focus group to discuss gene therapy. We are seeking to understand the concerns and questions the community has around this potential new treatment. The focus group will last for …
Vaccination program for COVID-19 in patients with Gaucher disease
14 gennaio 2021
The EWGGD and IGA are standing together with the Gaucher patients’ community in this challenging time of the COVID-19 pandemic, and we are strongly supportive of the vaccination program for COVID-19 and hopes that any patient who is offered …
A Charitable Access Program for patients with lysosomal storage disorders in underserved communities worldwide
8 gennaio 2021
A paper on a Charitable Access Program for patients with lysosomal storage disorders in underserved communities worldwide has now been published online on the Orphanet Journal of Rare Diseases (OJRD) website.
IGA's CEO, Tanya Collin-Histed …
December newsletter and office opening hours
8 dicembre 2020
Seasonal greetings from all of us here at the IGA…
2020 has been a difficult year for us all - but one that has brought us closer as a community, so thank you to everyone for their support and for following us here on social media, helping …
WATCH NOW: Digital health technology webinar
11 novembre 2020
If you missed the last of our educational webinars for 2020 which focussed on digital health technology, you can watch it here
Our thanks to Aparito, Backpack and Patient Discovery who presented their technologies and demonstrated how …